Who Should Receive EarlyCDT^™-Lung?

EarlyCDT^™-Lung's diverse test panel, along with the ability of the autoantibody assay to identify low levels of autoantibodies, can aid in detection of cancer earlier than other routine testing procedures and improves the potential for a positive outcome. EarlyCDT^™-Lung is particularly appropriate for men and women who are at increased risk for lung cancer.

In terms of lung cancer detection, EarlyCDT^™-Lung is an important breakthrough in technology. Its power to detect cancer before other examination and imaging techniques means more men and women will receive earlier diagnosis and treatment.